is tirzepatide safer than semaglutide vs. Semaglutide: Which Best for Weight Loss? Tirzepatide vs semaglutide dosage chart:

Unlike currently approved GLP-1 receptor agonists or dual agonists, Retatrutide simultaneously activates three distinct metabolic pathways

In a recent paper in The New England Journal of Medicine, physician Amanda Banks noted that the proportion of GLP-1 prescriptions written for people who were not diabetic, obese, or overweight increased from 4.5% in 2018 to 17% in 2023

You can see these transformations in our Success Stories page

A Lancet study found that people who built an exercise habit while on a GLP-1 were more likely to maintain weight loss after stopping the drug than those who relied on medication alone

L., Trivedi, M., et al

I consider blood work the single most important harm reduction practice